BioTech Capital Ltd utilises the services of Foursight Associates Pty Ltd ("Foursight") as Scientific Adviser. Foursight Limited will evaluate investment proposals from a scientific and biomedical standpoint and produce a report providing an assessment of the technical merits of those proposals.
The four principals of Foursight are highly respected members of the Australian scientific and medical professions.
Sir Gustav Nossal AC CBE
After graduating in medicine at Sydney University, Sir Gustav became a research Fellow at the Walter and Eliza Hall institute of Medical Research, achieving a PhD and ultimately Directorship of the Hall Institute in 1965. He was also Professor of Medical Biology at the University of Melbourne.
Sir Gustav has written 5 books and 500 scientific articles. His eminence in the field was recognised by his election as President of the world body of immunology, the International Union of Immunological Societies from 1986 to 1989. He has also served as President of the Australian Academy of Science, a member of the Prime Minister's Science, Engineering and Innovation Council and a member of the Board of CSIRO. He chairs the World Health Organisation Commitee overseeing the global programme for vaccines and immunisation. He was knighted in 1977, then made a Companion of the order of Australia, and was awarded Australian of the Year 2000. He has also recieved honours in the USA, the UK and other countries.
Dr Graham Mitchell AO
A Veterinary graduate and University Gold Medallist of the University of Sydney, Graham made discoveries in cellular immunology at the Walter and Eliza Hall Institute and obtained a PhD in 1969. He gained research experience in the USA, UK and Switzerland and returned to Australia to establish a new programme in immunoparasitology at the Walter and Eliza Hall Insitute and was instrumental in establishing a long-term programme with the disease schistomiasis in the Philippines. Graham has been a director of the Royal Melbourne Zoological Gardens and a Director in Research in R&D at CSL Limited. He has worked with the World Health Organisation, written more than 350 publications and was awarded Officer of the Order of Australia for services to medical science. Graham is a principal adviser in Science, Engineering and Technology to the Victorian Government and a non-executive director of several listed biotechnology companies.
Dr John Stocker AO
Following his medical studies at the University of Melbourne, and residency at the Royal Melbourne Hospital, John embarked on a career in medical research. He was a member of the Basel Institute for immunology in Switzerland and joined Hoffman La-Roche and Co in the company's central research unit. He became Roche's Director of Pharmacuetical Research in 1986. He returned to Australia in 1987 to become founding Managing Director of AMRAD Corporation Ltd. From 1990-1995 he served as Chief Executive Officer of CSIRO. He was appointed Chief Scientist to the Commonwealth Government in 1996. He is Chairman of Sigma Company Ltd of the Grape and Wine Research and Development Corporation. He is a Director of Telstra Corporation Ltd, Cambridge Antibody Technology Group plc and Circadian Technologies Ltd. He has been a member of the Prime Minister's Science, Engineering and Innovation Council, the Australian Research Council and Chairman of the Australian Science Technology and Engineering Council (ASTEC).
Professor David Penington AC
A graduate of Oxford University, David was a medical practitioner, teacher and researcher in London. He returned to Australia and was appointed Professor of Medicine at the University of Melbourne in 1970 and Dean of the Faculty of Medicine from 1978 to 1986. In 1988 Professor Penington was appointed a Companion of the Order of Australia for services to medicine and the community. He has been Chairman of the National Blood Transfusion Commitee of the Australian Red Cross Society, Director of the Tianjin Blood Transfusion Development Program, Chief Adviser on Health Policy to the Victorian Health Department and Board member of the Royal Melbourne Hospital, the Walter and Eliza Hall Institute, the Peter McCallum Cancer Institute and the Ludwig Institute for Cancer Research. David is a former Chairman of Cochlear Limited (the Company which developed and manufactures the "bionic ear"). He is Professor Emeritus of the University of Melbourne.